Chirfi Guindo - Dec 2, 2024 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Director
Signature
By: Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/4/2024, 07:22 AM
Previous filing
Aug 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +39.1K $0.00 39.1K Dec 2, 2024 Common Stock 39.1K $28.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter, subject to the Reporting Person's continued service with the Company through each vesting date.